Find out more about Damien Kee's experience
Damien Kee's highlights
Damien Kee's selected work
iPREDICT: Incorporating complex profiling of patients to enrol onto molecularly directed c..
Anti-programmed cell death protein 1 (anti-PD1) immunotherapy induced autoimmune polyendoc..
MEK Inhibitor Therapy in Carcinomas With RAF1 Fusions: Inferior Response in a Patient With..
A phase II clinical trial of ipilimumab/nivolumab combination immunotherapy in patients wi..
Rheumatic immune-related adverse events secondary to anti-programmed death-1 antibodies an..
Displaying the 9 most recent scholarly works by Damien Kee.
CART-WHEEL.org: An Ethically Approved Online Database for Patient-Entered Data to Facilitate Rare Cancer Research.
Damien Kee, Clare Parker, Susie Bae, Katherine M Tucker, Michelle Harrison, Ibrahim Tohidi-Esfahani, Marita Black, Rachel Delahunty, Sumitra Ananda, Michael Friedlander, Heather E Cunliffe, Peter Gibbs, Jayesh Desai, Judith Trotman, Clare L Scott
Journal article | 2020 | JCO Clinical Cancer Informatics
PURPOSE: Rare cancers are challenging for researchers, as clinicians and scientists have difficulty recruiting sufficient patient ..
iPREDICT: Incorporating complex profiling of patients to enrol onto molecularly directed cancer therapeutics. Preliminary results of the adult and paediatric
Kortnye Smith, Sophie O'Haire, Khuong-Quang Dong-Anh, Ben Markman, Hui Gan, Paul G Ekert, Ken O'Byrne, Michael Milward, Ben Solomon, Ben Tran, Clare Scott, Grant McArthur, Damien Kee, Andrew Fellowes, Huiling Xu, Melissa Martyn, Elly Lynch, Paula Lorgelly, Clara Gaff, Stephen Fox, et al.
Conference Proceedings | 2019 | ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY
MEK Inhibitor Therapy in Carcinomas With RAF1 Fusions: Inferior Response in a Patient With Pancreatic Acinar Cell Carcinoma
Christopher R McEvoy, Damien Kee, Owen WJ Prall, Timothy D Clay, Clare Scott, Anastasia Backhouse, Stephen B Fox, Andrew P Fellowes, Huiling Xu
Journal article | 2019 | JCO Precision Oncology
A phase II clinical trial of ipilimumab/nivolumab combination immunotherapy in patients with rare upper gastrointestinal, neuroendocrine, and gynecological malignancies.
Oliver Klein, Damien Kee, Ben Markman, Rachael Chang Lee, Michael Michael, Linda R Mileshkin, Clare L Scott, Richelle Linklater, Sid Menon, Niall C Tebbutt, Jodie Palmer, Andreas Behren, Jonathan S Cebon
Conference Proceedings | 2019 | Journal of Clinical Oncology
Rheumatic immune-related adverse events secondary to anti-programmed death-1 antibodies and preliminary analysis on the impact of corticosteroids on anti-tumour response: A case series
Emma L Mitchell, Peter Kar Han Lau, Chloe Khoo, David Liew, Jessica Leung, Bonnia Liu, Adam Rischin, Albert G Frauman, Damien Kee, Kortnye Smith, Benjamin Brady, Danny Rischin, Andrew Gibson, Linda Mileshkin, Oliver Klein, Andrew Weickhardt, Surein Arulananda, Mark Shackleton, Grant McArthur, Andrew Ostor, et al.
Journal article | 2018 | European Journal of Cancer
Surveillance imaging with FDG-PET/CT in the post-operative follow-up of stage 3 melanoma
J Lewin, L Sayers, D Kee, I Walpole, A Sanelli, L te Marvelde, A Herschtal, J Spillane, D Gyorki, D Speakman, V Estall, S Donahoe, M Pohl, K Pope, M Chua, S Sandhu, GA McArthur, CJ McCormack, M Henderson, RJ Hicks, et al.
Journal article | 2018 | Annals of Oncology
Circulating Tumor DNA Analysis and Functional Imaging Provide Complementary Approaches for Comprehensive Disease Monitoring in Metastatic Melanoma
Stephen Q Wong, Jeanette M Raleigh, Jason Callahan, Ismael A Vergara, Sarah Ftouni, Athena Hatzimihalis, Andrew J Colebatch, Jason Li, Timothy Semple, Kenneth Doig, Christopher Mintoff, Devbarna Sinha, Paul Yeh, Maria Joao Silva, Kathryn Alsop, Heather Thorne, David D Bowtell, David E Gyorki, Gisela Mir Arnau, Carleen Cullinane, et al.
Journal article | 2017 | JCO Precision Oncology
Medical Biology (W.E.H.I.)